Publications by authors named "S Abner"
Article Synopsis
- Duchenne muscular dystrophy (DMD) leads to severe muscle degeneration and increased risk of heart problems; the review aimed to identify factors predicting cardiac disease in DMD patients.
- The systematic review examined literature from 2000 to 2022, analyzing 33 studies involving over 9,200 DMD patients and assessing the strength of the evidence using the GRADE framework.
- Key findings indicated that certain cardiac medications and DMD gene mutations are linked to better heart function, while glucocorticoids improve left ventricular performance, with varying evidence quality regarding their effectiveness.
The search for an efficient and stable catalyst for the electrochemical reduction of CO to value-added chemicals is especially critical for lowering the atmospheric CO concentration. In this study, self-supported cobalt/copper nanostructured catalysts were designed, where the influences of the elemental composition and acid-etching on their efficiency towards the CO reduction reaction were studied. The developed Co/Cu catalysts showed superb catalytic activity with a low onset potential at -0.
View Article and Find Full Text PDFObjective: The objective of this study was to describe predictors of loss of ambulation in Duchenne muscular dystrophy (DMD).
Methods: This systematic review and meta-analysis included searches of MEDLINE ALL, Embase, and the Cochrane Database of Systematic Reviews from January 1, 2000, to December 31, 2022, for predictors of loss of ambulation in DMD. Search terms included "Duchenne muscular dystrophy" as a Medical Subject Heading or free text term, in combination with variations of the term "predictor".
Article Synopsis
- The article discusses the NHSN's use of automation in public health surveillance through digital quality measures (dQMs) using an open-source tool called NHSNLink, and a pilot program (NHSNCoLab) with real-world data.
- It focuses on leveraging FHIR APIs to enhance data collection and reporting related to significant and preventable patient harms like medication-related complications and infections.
- The findings suggest that implementing FHIR dQMs can reduce reporting burdens while improving the accuracy, quality, and efficiency of data for public health and patient safety.
Background And Objectives: Bisphosphonates are routinely used to treat osteoporosis in patients with Duchenne muscular dystrophy (DMD), a rare, severely debilitating neuromuscular disease. We sought to synthesize and grade benefits and harms evidence of bisphosphonates in glucocorticoid-treated patients with DMD.
Methods: In this systematic review (PROSPERO identifier: CRD42020157606), we searched MEDLINE, CINAHL, Embase, PsycINFO, Web of Science, and CENTRAL for articles published from inception up to and including March 31, 2023, reporting results in any language from any study type.